Abstract

Fractalkine is a new member of chemokine family, which exists in membranebound form and soluble form. It has both adhesion molecular and chemokine activities. CX3 CR1 is its specific receptor. Both of them were expressed in many diseases of the nervous system. At present, fractalkine and its receptor CX3 CR1 polymorphism and the research of cerebrovascular diseases mainly involve in the risk factors for cerebrovascular diseases, cerebral ischemiareperfusion and bone marrow stem cell transplantion, which are expected to become a new target for clinical treatment. Key words: Cerebrovascular disorders; Brain ischemia; Reperfusion injury; Chemokines, CX3C; Receptors, cytokine; Polymorphism, genetic

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.